Commonly used in vivo models of prostate cancer metastasis include syngenei
c rodent cancers and xenografts of human cancer in immunodeficient mice. Ho
wever, the occurrence of osseous metastases in these models is rare, and in
xenograft models, species-specific factors may limit the ability of human
cells to metastasize to rodent bones, We have modified the severe combined
immunodeficient (SCID)-human model to test the ability of circulating human
prostate cancer cells to home to macroscopic fragments of human bone and o
ther organs previously implanted into SCID mice, We have also compared the
growth of human prostate cancer cells in various human and mouse tissue mic
roenvironments in vivo. Macroscopic fragments of human fetal bone, lung, or
intestine (16-22 weeks gestation) or mouse bone were implanted s.c, into m
ale CB.17 SCID mice. Four weeks later, human prostate cancer cells were inj
ected either i.v. via the tail vein (circulating cell colonization assay) o
r directly into the implanted tissue fragments transdermally (end organ gro
wth assay). Tumor growth was followed for 6 weeks by palpation and magnetic
resonance imaging. After 6 weeks, tumors were enumerated in implanted huma
n and mouse organ fragments and native mouse tissue. Tumors were characteri
zed by histology, immunohistochemistry, and chromosomal analysis. After i.v
. injection, circulating PC3 cells successfully colonized implanted human b
one fragments in 5 of 19 mice, Tumors were easily followed by palpation and
imaging and had an average volume of 258 mm(3) at autopsy. Histological ex
amination revealed osteolysis and a strong desmoplastic stromal response, w
hich indicated intense stromal-epithelial interaction. Bone tumors were sub
cultured, and chromosomal analysis demonstrated that the tumors were derive
d from the parental prostate cancer cell Line, Microscopic tumor colonies w
ere also found in a few mouse lungs after i.v. injection of PC3, DU145, and
LNCaP cells, however the volume of the lung nodules was less than 1 mm(3)
in all of the cases. No colonization of human lung or intestine implants, t
he mouse skeleton, or other mouse organs was detected, demonstrating a spec
ies and tissue-specific colonization of human bone by PC3 cells. Direct inj
ection of 10(4) prostate cancer cells into human bone implants resulted in
large tumors in 75-100% of mice. PC3 and DU145 bone tumors were primarily o
steolytic, whereas LNCaP bone tumors were both osteoblastic and osteolytic,
PC3 and LNCaP bone tumors showed a desmoplastic stromal response, which in
dicated intense stromal-epithelial interaction. All three of the cell lines
formed tumors in implanted human lung tissue; however, the tumors were all
less than or equal to 10 mm(3) in volume and showed minimal stromal involv
ement. No tumors formed after either s.c. injection or injection of cells i
nto implanted mouse bone demonstrating both species and tissue-specific enh
ancement of growth of human prostate cancer cells by human bone. The severe
combined immunodeficient-human model provides a useful system to study spe
cies-specific mechanisms involved in the homing of human prostate cancer ce
lls to human bone and the growth of human prostate cancer cells in human bo
ne.